Vivonics, Inc.

Vivonics is looking for research volunteers to participate in a study to test a physiological monitoring smart garment. More information, including contact information, can be found in the flyer below:

Vivonics, Inc. Founder and CEO, Gordon Hirschman, presents a commemorative clock to Lead Electrical Engineer Eric Louis on the occasion of his retirement. Eric was one of the original employees who worked for Mr. Hirschman at Infoscitex Corporation (IST) and joined Vivonics in 2012 when it acquired the assets of the IST Biomedical Division. Eric is looking forward to a leisurely retirement living at the lake and enjoying time with his grandchildren. Congratulations Eric!

Vivonics, Inc. Awarded $999,962 Contract from US Marine Corps for Continued Development of Traumatic Brain Injury Treatment System Vivonics, Inc. is pleased to announce the award of contract M67854-24-C-6544 from the U.S. Marine Corps (USMC) for $999,962 to advance the development of the Intranasal Cooling for Encephalopathy Prevention in Combat Casualties (ICEPICC) system. The ICEPICC system is a breakthrough technology aimed at mitigating the effects of traumatic brain injury (TBI) in combat trauma care. Vivonics is collaborating closely with NeuroIntact, Inc., a partner that has licensed the technology from Vivonics for commercialization. NeuroIntact CEO Bryan Nicholson emphasized the significance of this partnership, stating, “Through our partnership with Vivonics, we’ve gained a deep understanding of the brain injuries faced by our soldiers. The funding raised by NeuroIntact, along with the grant from the Marine Corps, will advance the development of our intranasal Targeted Temperature Management (TTM) therapy. This therapy has the potential to bring about a paradigm shift in the treatment of brain injuries for both military and civilian patients.” For more information, see our press release at: https://lnkd.in/eTmAGhTH

Vivonics is excited to announce that we have been awarded a $319,000 grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) for Phase I development of our Galvanic Vestibular Stimulation (GVS) technology to treat the symptoms of Ménière's disease, led jointly by our CEO Gordon Hirschman and Devin L. McCaslin, Ph.D. of the University of Michigan, with key support from Mindy Bishop, PhD at Vivonics. Ménière's disease is a debilitating illness characterized by episodic attacks of vertigo, which can make many activities of daily living dangerous or impossible. GVS is an innovative technology that allows for treatment of vertigo and balance issues by applying electricity via the skin to the vestibular system, a key component of balance in humans. Vivonics has been developing GVS technology over the past decade for many different applications to explore new ways of treating these conditions without pharmaceuticals or invasive implants, and this project is the latest extension of that work. An important part of this program will include a human study in collaboration with Dr. McCaslin to demonstrate the effectiveness of the system. With this technology, sufferers of Ménière's disease will have a new way of treating their symptoms without the side effects of drugs or other conventional methods, allowing them to resume their normal lives in safety and comfort. Thanks to everyone at Vivonics for making this happen!

Vivonics had a great opportunity at #MHSRS2024 to present some of the exciting work we are doing! Michaelina Dupnik and Joshua Colls of Vivonics presented on our Vestibular Intervention via Portable Electrical Stimulator (VIPES), E‐Textile Enabled Active Monitoring System (E-TEAMS), and Next-Generation Virtual Health (NGVH) projects, and were also joined by Joshua Gatson, PhD, MS, PMP of General Dynamics Information Technology, one of our collaborators on the NGVH project. View the posters on our site: https://lnkd.in/eKyukwyP

Michaelina Dupnik and Joshua Colls recently presented on behalf of Vivonics at the 2024 Military Health System Research Symposium (MHSRS) in Kissimmee, FL. Further information on the conference, as well as the posters presented, can be found on our website below. #MHSRS #MHSRS2024

Vivonics is pleased to announce that we have been awarded a $197,000 contract from the United States Department of Defense Chemical and Biological Defense Program for Phase I development of our Continuous Thermal Strain Monitoring and Prevention (CTS-MAP) system, spearheaded by Dr. Michele Pierro. Military servicemembers often need to wear heavy protective gear in hazardous environments, which puts them at risk for heat stress and heatstroke. To prevent this, the military utilizes personal cooling systems; however, for the cooling systems to be used optimally and power consumption to be minimized, a method is needed to detect the onset of heat stress so cooling can be activated only when needed. CTS-MAP uses a novel optical approach to identify key markers of early heat stress in servicemembers, ensuring that they can be provided with optimal personal cooling to preserve their health, safety, and effectiveness. Thanks to the entire Vivonics team for making this happen!

On this Memorial Day, we remember and honor the men and women of the Armed Forces who gave their lives in the service of their country. Vivonics is dedicated to the development of novel medical technology for the United States military in the hopes that with it, the lives of injured servicemembers can be saved and they have the best care possible so they can return home to continue to live long, productive lives.

--No longer accepting applications-- We're #hiring for a Biomedical Engineering Co-op! We're looking for a self-motivated and enthusiastic person with a passion for engineering and research to improve human health and performance. The BME co-op will be integral to both our engineering and clinical programs. Know anyone who may be a good fit? Apply on our website!

Meet Vivonics Founder and CEO Gordon Hirschman at the NextFlex Workshop "Advancing Electronics Packaging of Hybrid Electronics for Industrial and Medical Applications" at Binghamton University next week on April 18th!